Enzymes最新文献

筛选
英文 中文
Drug design of tyrosinase inhibitors. 酪氨酸酶抑制剂的药物设计。
Enzymes Pub Date : 2024-01-01 Epub Date: 2024-06-25 DOI: 10.1016/bs.enz.2024.06.001
Francesco Melfi, Simone Carradori, Arianna Granese, Amar Osmanović, Cristina Campestre
{"title":"Drug design of tyrosinase inhibitors.","authors":"Francesco Melfi, Simone Carradori, Arianna Granese, Amar Osmanović, Cristina Campestre","doi":"10.1016/bs.enz.2024.06.001","DOIUrl":"10.1016/bs.enz.2024.06.001","url":null,"abstract":"<p><p>This copper-containing enzyme catalyzes the rate-limiting step for the melanin skin pigment bioproduction. Tyrosinase inhibitors can be exploited as skin whitening agents and food preservatives, opening new scenarios in food, cosmetics, agriculture and medicine. Despite the availability of natural inhibitors (hydroquinone, α-arbutin, kojic acid, retinoids, azelaic acid, resveratrol, caftaric acid, valonea tannin, chrysosplenetin and phenylethyl resorcinol), several synthetic compounds were proposed to overcome side effects and to improve the efficacy of natural agents. This chapter will gather the recent advances about synthetic tyrosinase inhibitors from the MedChem perspective, providing new suggestions for the scaffold-based design of innovative compounds.</p>","PeriodicalId":39097,"journal":{"name":"Enzymes","volume":"56 ","pages":"111-134"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142297670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges for developing bacterial CA inhibitors as novel antibiotics. 开发细菌 CA 抑制剂作为新型抗生素所面临的挑战。
Enzymes Pub Date : 2024-01-01 Epub Date: 2024-07-03 DOI: 10.1016/bs.enz.2024.05.006
Claudiu T Supuran
{"title":"Challenges for developing bacterial CA inhibitors as novel antibiotics.","authors":"Claudiu T Supuran","doi":"10.1016/bs.enz.2024.05.006","DOIUrl":"https://doi.org/10.1016/bs.enz.2024.05.006","url":null,"abstract":"<p><p>Acetazolamide, methazolamide, ethoxzolamide and dorzolamide, classical sulfonamide carbonic anhydrase (CA) inhibitors (CAIs) designed for targeting human enzymes, were also shown to effectively inhibit bacterial CAs and were proposed for repurposing as antibacterial agents against several infective agents. CAs belonging to the α-, β- and/or γ-classes from pathogens such as Helicobacter pylori, Neisseria gonorrhoeae, vacomycin resistant enterococci (VRE), Vibrio cholerae, Mycobacterium tuberculosis, Pseudomonas aeruginosa and other bacteria were considered as drug targets for which several classes of potent inhibitors have been developed. Treatment of some of these pathogens with various classes of such CAIs led to an impairment of the bacterial growth, reduced virulence and for drug resistant bacteria, a resensitization to clinically used antibiotics. Here I will discuss the strategies and challenges for obtaining CAIs with enhanced selectivity for inhibiting bacterial versus human enzymes, which may constitute an important weapon for addressing the drug resistance to β-lactams and other clinically used antibiotics.</p>","PeriodicalId":39097,"journal":{"name":"Enzymes","volume":"55 ","pages":"383-411"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-sulfonamide bacterial CA inhibitors. 非磺酰胺细菌 CA 抑制剂。
Enzymes Pub Date : 2024-01-01 Epub Date: 2024-07-20 DOI: 10.1016/bs.enz.2024.06.007
Fabrizio Carta
{"title":"Non-sulfonamide bacterial CA inhibitors.","authors":"Fabrizio Carta","doi":"10.1016/bs.enz.2024.06.007","DOIUrl":"https://doi.org/10.1016/bs.enz.2024.06.007","url":null,"abstract":"<p><p>Non-sulfonamide chemical moieties able to inhibit the bacterial (b) expressed Carbonic Anhydrases (CAs; EC 4.2.1.1) constitute an important alternative to the prototypic modulators discussed in Chapter 6, as give access to large and variegate chemical classes, also of the natural origin. This contribution reports the main classes of compounds profiled in vitro on the bCAs and thus may be worth developing for the validation process of this class of enzymes.</p>","PeriodicalId":39097,"journal":{"name":"Enzymes","volume":"55 ","pages":"193-212"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carbonic anhydrases in bacterial pathogens. 细菌病原体中的碳酸酐酶。
Enzymes Pub Date : 2024-01-01 Epub Date: 2024-06-06 DOI: 10.1016/bs.enz.2024.05.007
Reygan E Braga, Fares Z Najar, Chelsea L Murphy, Marianna A Patrauchan
{"title":"Carbonic anhydrases in bacterial pathogens.","authors":"Reygan E Braga, Fares Z Najar, Chelsea L Murphy, Marianna A Patrauchan","doi":"10.1016/bs.enz.2024.05.007","DOIUrl":"https://doi.org/10.1016/bs.enz.2024.05.007","url":null,"abstract":"<p><p>Carbonic anhydrases (CAs) catalyze the reversable hydration of carbon dioxide to bicarbonate placing them into the core of the biochemical carbon cycle. Due to the fundamental importance of their function, they evolved independently into eight classes, three of which have been recently discovered. Most research on CAs has focused on their representatives in eukaryotic organisms, while prokaryotic CAs received significantly less attention. Nevertheless, prokaryotic CAs play a key role in the fundamental ability of the biosphere to acquire CO<sub>2</sub> for photosynthesis and to decompose the organic matter back to CO<sub>2</sub>. They also contribute to a broad spectrum of processes in pathogenic bacteria, enhancing their ability to survive in a host and, therefore, present a promising target for developing antimicrobials. This review focuses on the distribution of CAs among bacterial pathogens and their importance in bacterial virulence and host-pathogen interactions.</p>","PeriodicalId":39097,"journal":{"name":"Enzymes","volume":"55 ","pages":"313-342"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural products as tyrosinase inhibitors. 天然产品作为酪氨酸酶抑制剂。
Enzymes Pub Date : 2024-01-01 Epub Date: 2024-06-25 DOI: 10.1016/bs.enz.2024.06.002
Aslınur Doğan, Suleyman Akocak
{"title":"Natural products as tyrosinase inhibitors.","authors":"Aslınur Doğan, Suleyman Akocak","doi":"10.1016/bs.enz.2024.06.002","DOIUrl":"10.1016/bs.enz.2024.06.002","url":null,"abstract":"<p><p>Tyrosinase is a crucial copper-containing enzyme involved in the production of melanin. Melasma, age spots, and freckles are examples of hyperpigmentation diseases caused by excess production of melanin. Inhibiting tyrosinase activity is a crucial method for treating these disorders along with various applications such as cosmetics, food technology, and medicine. Natural products have proven a rich source of tyrosinase inhibitors, with several molecules from plant, marine, and microbial sources showing potential inhibitory action. This chapter provides a complete overview of natural compounds that have been found as tyrosinase inhibitors, with emphasis on their structures, modes of action, and prospective applications.</p>","PeriodicalId":39097,"journal":{"name":"Enzymes","volume":"56 ","pages":"85-109"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142297671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies. 分枝杆菌的β-碳酸酐酶:分子生物学、在结核病发病机制中的作用和抑制研究。
Enzymes Pub Date : 2024-01-01 Epub Date: 2024-08-06 DOI: 10.1016/bs.enz.2024.05.012
Jenny Parkkinen, Ratul Bhowmik, Martti Tolvanen, Fabrizio Carta, Claudiu T Supuran, Seppo Parkkila, Ashok Aspatwar
{"title":"Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies.","authors":"Jenny Parkkinen, Ratul Bhowmik, Martti Tolvanen, Fabrizio Carta, Claudiu T Supuran, Seppo Parkkila, Ashok Aspatwar","doi":"10.1016/bs.enz.2024.05.012","DOIUrl":"https://doi.org/10.1016/bs.enz.2024.05.012","url":null,"abstract":"<p><p>Mycobacterium tuberculosis (Mtb), which causes tuberculosis (TB), is still a major global health problem. According to the World Health Organization (WHO), TB still causes more deaths worldwide than any other infectious agent. Drug-sensitive TB is treatable using first-line drugs; treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB requires second- and third-line drugs. However, due to the long duration of treatment, the noncompliance of patients with different levels of resistance of Mtb to these drugs has worsened the situation. Previously developed anti-TB drugs targeted the replication machinery, protein synthesis, and cell wall biosynthesis pathways of Mtb. Therefore, novel drugs targeting alternate pathways crucial for the survival and pathogenesis of Mtb in the human host are needed. The genome of Mtb encodes three β-carbonic anhydrases (CAs) that are fundamental for pH homeostasis, hypoxia, survival, and pathogenesis. Recently, several studies have shown that the β-CAs of Mtb could be inhibited both in vitro and in vivo using small chemical molecules, suggesting that these enzymes could be novel targets for developing anti-TB compounds that are devoid of resistance by Mtb. In addition, homologs of β-CAs are absent in humans; therefore, drugs developed to target these enzymes might have minimal off-target effects. In this work, we describe the roles of β-CAs in Mtb and discuss bioinformatics and cheminformatics tools used in development and discovery of novel inhibitors of these enzymes. In addition, we summarize the in vitro and in vivo studies demonstrating that the β-CAs of Mtb are indeed druggable targets.</p>","PeriodicalId":39097,"journal":{"name":"Enzymes","volume":"55 ","pages":"343-381"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Helicobacter pylori CAs inhibition. 幽门螺旋杆菌 CAs 抑制剂。
Enzymes Pub Date : 2024-01-01 Epub Date: 2024-06-08 DOI: 10.1016/bs.enz.2024.05.013
Bianca Laura Bernardoni, Concettina La Motta, Simone Carradori, Ilaria D'Agostino
{"title":"Helicobacter pylori CAs inhibition.","authors":"Bianca Laura Bernardoni, Concettina La Motta, Simone Carradori, Ilaria D'Agostino","doi":"10.1016/bs.enz.2024.05.013","DOIUrl":"https://doi.org/10.1016/bs.enz.2024.05.013","url":null,"abstract":"<p><p>Infections from Helicobacter pylori (Hp) are endangering Public Health safety worldwide, due to the associated high risk of developing severe diseases, such as peptic ulcer, gastric cancer, diabetes, and cardiovascular diseases. Current therapies are becoming less effective due to the rise of (multi)drug-resistant phenotypes and an urgent need for new antibacterial agents with innovative mechanisms of action is pressing. Among the most promising pharmacological targets, Carbonic Anhydrases (EC: 4.2.1.1) from Hp, namely HpαCA and HpβCA, emerged for their high druggability and crucial role in the survival of the pathogen in the host. Thereby, in the last decades, the two isoenzymes were isolated and characterized offering the opportunity to profile their kinetics and test different series of inhibitors.</p>","PeriodicalId":39097,"journal":{"name":"Enzymes","volume":"55 ","pages":"213-241"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacterial β-carbonic anhydrases. 细菌β-碳酸酐酶。
Enzymes Pub Date : 2024-01-01 Epub Date: 2024-08-16 DOI: 10.1016/bs.enz.2024.05.009
Marta Ferraroni
{"title":"Bacterial β-carbonic anhydrases.","authors":"Marta Ferraroni","doi":"10.1016/bs.enz.2024.05.009","DOIUrl":"https://doi.org/10.1016/bs.enz.2024.05.009","url":null,"abstract":"<p><p>β-Carbonic anhydrases (β-CA; EC 4.2.1.1) are widespread zinc metalloenzymes which catalyze the interconversion of carbon dioxide and bicarbonate. They have been isolated in many pathogenic and non-pathogenic bacteria where they are involved in multiple roles, often related to their growth and survival. β-CAs are structurally distant from the CAs of other classes. In the active site, located at the interface of a fundamental dimer, the zinc ion is coordinated to two cysteines and one histidine. β-CAs have been divided in two subgroups depending on the nature of the fourth ligand on the zinc ion: class I have a zinc open configuration with a hydroxide ion completing the metal coordination, which is the catalytically active species in the mechanism proposed for the β-CAs similar to the well-known of α-CAs, while in class II an Asp residue substitute the hydroxide. This latter active site configuration has been showed to be typical of an inactive form at pH below 8. An Asp-Arg dyad is thought to play a key role in the pH-induced catalytic switch regulating the opening and closing of the active site in class II β-CAs, by displacing the zinc-bound solvent molecule. An allosteric site well-suited for bicarbonate stabilizes the inactive form. This bicarbonate binding site is composed by a triad of well conserved residues, strictly connected to the coordination state of the zinc ion. Moreover, the escort site is a promiscuous site for a variety of ligands, including bicarbonate, at the dimer interface, which may be the route for bicarbonate to the allosteric site.</p>","PeriodicalId":39097,"journal":{"name":"Enzymes","volume":"55 ","pages":"65-91"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catalytic mechanism of tyrosinases. 酪氨酸酶的催化机制。
Enzymes Pub Date : 2024-01-01 Epub Date: 2024-05-24 DOI: 10.1016/bs.enz.2024.05.001
Samaneh Zolghadri, Ali Akbar Saboury
{"title":"Catalytic mechanism of tyrosinases.","authors":"Samaneh Zolghadri, Ali Akbar Saboury","doi":"10.1016/bs.enz.2024.05.001","DOIUrl":"https://doi.org/10.1016/bs.enz.2024.05.001","url":null,"abstract":"<p><p>Tyrosinases (TYR) play a key role in melanin biosynthesis by catalyzing two reactions: monophenolase and diphenolase activities. Despite low amino acid sequence homology, TYRs from various organisms (from bacteria to humans) have similar active site architectures and catalytic mechanisms. The active site of the TYRs contains two copper ions coordinated by histidine (His) residues. The catalytic mechanism of TYRs involves electron transfer between copper sites, leading to the hydroxylation of monophenolic compounds to diphenols and the subsequent oxidation of these to corresponding dopaquinones. Although extensive studies have been conducted on the structure, catalytic mechanism, and enzymatic capabilities of TYRs, some mechanistic aspects are still debated. This chapter will delve into the structure of the active site, catalytic function, and inhibition mechanism of TYRs. The goal is to improve our understanding of the molecular mechanisms underlying TYR activity. This knowledge can help in developing new strategies to modulate TYR function and potentially treat diseases linked to melanin dysregulation.</p>","PeriodicalId":39097,"journal":{"name":"Enzymes","volume":"56 ","pages":"31-54"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142297668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacterial tyrosinases and their inhibitors. 细菌酪氨酸酶及其抑制剂。
Enzymes Pub Date : 2024-01-01 Epub Date: 2024-08-03 DOI: 10.1016/bs.enz.2024.06.003
Ali Irfan, Yousef A Bin Jardan, Laila Rubab, Huma Hameed, Ameer Fawad Zahoor, Claudiu T Supuran
{"title":"Bacterial tyrosinases and their inhibitors.","authors":"Ali Irfan, Yousef A Bin Jardan, Laila Rubab, Huma Hameed, Ameer Fawad Zahoor, Claudiu T Supuran","doi":"10.1016/bs.enz.2024.06.003","DOIUrl":"https://doi.org/10.1016/bs.enz.2024.06.003","url":null,"abstract":"<p><p>Bacterial tyrosinase is a copper-containing metalloenzyme with diverse physio-chemical properties, that have been identified in various bacterial strains, including actinobacteria and proteobacteria. Tyrosinases are responsible for the rate-limiting catalytic steps in melanin biosynthesis and enzymatic browning. The physiological role of bacterial tyrosinases in melanin biosynthesis has been harnessed for the production of coloring and dyeing agents. Additionally, bacterial tyrosinases have the capability of cross-linking activity, demonstrated material functionalization applications, and applications in food processing with varying substrate specificities and stability features. These characteristics make bacterial tyrosinases a valuable alternative to well-studied mushroom tyrosinases. The key feature of substrate specificity of bacterial tyrosinase has been exploited to engineer biosensors that have the ability to detect the minimal amount of different phenolic compounds. Today, the world is facing the challenge of multi-drugs resistance in various diseases, especially antibiotic resistance, skin cancer, enzymatic browning of fruits and vegetables, and melanogenesis. To address these challenges, medicinal scientists are developing novel chemotherapeutic agents by inhibiting bacterial tyrosinases. To serve this purpose, heterocyclic compounds are of particular interest due to their vast spectrum of biological activities and their potential as effective tyrosinase inhibitors. In this chapter, a plethora of research explores applications of bacterial tyrosinases in different fields, such as the production of dyes and pigments, catalytic applications in organic synthesis, bioremediation, food and feed applications, biosensors, wool fiber coating and the rationalized synthesis, and structure-activity relationship of bacterial tyrosinase inhibitors.</p>","PeriodicalId":39097,"journal":{"name":"Enzymes","volume":"56 ","pages":"231-260"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142297666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信